The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / ACR Advocacy: 2020 Year in Review

ACR Advocacy: 2020 Year in Review

January 11, 2021 • By Blair Solow, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

To say it has been an interesting (the science—and the memes!), tumultuous (the politics) and heartbreaking (the pandemic and social injustice) year is an understatement. There have been moments of grace and inspiration that I hope have kept everyone going. As we look to 2021, we take lessons from our experiences in 2020. Washington, D.C., is buzzing, with a new president, new members in the House and Senate, a new Congress (117th) and more COVID-19 legislation negotiations.

You Might Also Like
  • ACR Advocacy: 2019 Year in Review
  • ACR Convergence 2020: From Clinic to Capitol Hill Session Offers Insights into Advocacy, Regulatory Issues
  • Year in Review: The ACR/ARHP/RheumPAC’s Advocacy Efforts in 2017
Also By This Author
  • ACR Advocacy: 2019 Year in Review

2020 Year in Review
A colossal thank you to our Government Affairs Committee members, patient advocates, physicians and interprofessional team member advocates for taking advocacy virtual last year during a pandemic and making it a huge success. I am so grateful for the ACR staff and advocates for taking a leap of faith and jumping all in to virtual advocacy. There were 3,061 emails sent to Congress on rheumatology issues, 2,052,710 #Act4Arthritis Twitter impressions and 285 meetings with legislators and ACR/ARP volunteers and patients.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Our ACR advocacy team in D.C. (Lennie Shewmaker, JD, director of congressional affairs; Amanda Grimm Wiegrefe, MScHSRA, director of regulatory affairs; and Dan Redinger, manager of advocacy and policy affairs) and in our Atlanta office (Adam Cooper, senior director of government affairs, and Joseph Cantrell, JD, senior manager of state affairs) will continue their efforts on behalf of ACR/ARP members, along with Rachel Myslinski, vice president of practice, advocacy and quality, and the rest of her team.

Add “make a RheumPAC investment” to your to-do list as a new year’s resolution! These funds allow for nonpartisan meetings with lawmakers working on issues that impact rheumatology.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

2021 Physician Fee Schedule Final Rule
The win: The Centers for Medicare & Medicaid Services (CMS) finalized the 2021 Physician Fee Schedule Final Rule, with rheumatologists seeing an estimated boost in reimbursement of approximately 14-15%, to start in 2021. This was the second largest increase among all medical specialties.

Context: Each year, the CMS releases rules on physician reimbursement. They use recommendations from the American Medical Association’s Relative Value Scale Update Committee to guide decisions on how to pay physicians from a single pot of money. The CMS valued certain Current Procedural Terminology codes higher, including those often used by some subspecialties, and modified documentation requirements to reduce administrative burdens. In this zero-sum game, other specialties were not so fortunate, with losses in surgery, radiology and physical therapy. Given the pandemic and all practices struggling, recent COVID-19 legislation balanced the cuts some providers may see by adding $3 billion in new money, to increase Medicare Fee Schedule payments across the board by 3.75% in CY 2021.

Pages: 1 2 3 | Single Page

Filed Under: American College of Rheumatology, Legislation & Advocacy Tagged With: Blair Solow, Government Affairs Committee (GAC), legislation and advocacy

You Might Also Like:
  • ACR Advocacy: 2019 Year in Review
  • ACR Convergence 2020: From Clinic to Capitol Hill Session Offers Insights into Advocacy, Regulatory Issues
  • Year in Review: The ACR/ARHP/RheumPAC’s Advocacy Efforts in 2017
  • Year in Review: The Impact of Advocacy & RheumPAC in 2018

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)